Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2010 1
2011 4
2012 5
2013 5
2014 5
2015 5
2016 6
2017 9
2018 6
2019 9
2020 5
2021 6
2022 6
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Sarcoma Stem Cell Heterogeneity.
Hatina J, Kripnerova M, Houfkova K, Pesta M, Kuncova J, Sana J, Slaby O, Rodríguez R. Hatina J, et al. Among authors: pesta m. Adv Exp Med Biol. 2019;1123:95-118. doi: 10.1007/978-3-030-11096-3_7. Adv Exp Med Biol. 2019. PMID: 31016597 Review.
Urothelial Cancer Stem Cell Heterogeneity.
Kripnerova M, Parmar HS, Pesta M, Kohoutova M, Kuncova J, Drbal K, Rajtmajerova M, Hatina J. Kripnerova M, et al. Among authors: pesta m. Adv Exp Med Biol. 2019;1139:127-151. doi: 10.1007/978-3-030-14366-4_8. Adv Exp Med Biol. 2019. PMID: 31134499 Review.
Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer.
Pesta M, Shetti D, Kulda V, Knizkova T, Houfkova K, Bagheri MS, Svaton M, Polivka J. Pesta M, et al. Diagnostics (Basel). 2022 Jul 25;12(8):1799. doi: 10.3390/diagnostics12081799. Diagnostics (Basel). 2022. PMID: 35892510 Free PMC article. Review.
Oncogenic Fusions in Gliomas: An Institutional Experience.
Polivka J, Svajdler M, Priban V, Mracek J, Kasik P, Martinek P, Ptakova N, Sharif Bagheri M, Shetti D, Pesta M, Potuznik P, Topolcan O. Polivka J, et al. Among authors: pesta m. Anticancer Res. 2022 Apr;42(4):1933-1939. doi: 10.21873/anticanres.15671. Anticancer Res. 2022. PMID: 35347013
Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study.
Vermeire S, Lakatos PL, Ritter T, Hanauer S, Bressler B, Khanna R, Isaacs K, Shah S, Kadva A, Tyrrell H, Oh YS, Tole S, Chai A, Pulley J, Eden C, Zhang W, Feagan BG; LAUREL Study Group. Vermeire S, et al. Lancet Gastroenterol Hepatol. 2022 Jan;7(1):28-37. doi: 10.1016/S2468-1253(21)00295-8. Epub 2021 Nov 17. Lancet Gastroenterol Hepatol. 2022. PMID: 34798037 Clinical Trial.
66 results